Abstract:Background The first community transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant of concern (VOC) in Guangzhou, China occurred between May and June 2021. Herein, we describe the epidemiological characteristics of this outbreak and evaluate the implemented containment measures against this outbreak. Methodology/Principal findings Guangzhou Center for Disease Control and Prevention provided the data on SARS-CoV-2 infections reported between 21 May and 24 June 2021. We estimated the incubation period distribution by fitting a gamma distribution to the data, while the serial interval distribution was estimated by fitting a normal distribution. The instantaneous effective reproductive number (R-t) was estimated to reflect the transmissibility of SARS-CoV-2. Clinical severity was compared for cases with different vaccination statuses using an ordinal regression model after controlling for age. Of the reported local cases, 7/153 (4.6%) were asymptomatic. The median incubation period was 6.02 (95% confidence interval [CI]: 5.42-6.71) days and the means of serial intervals decreased from 5.19 (95% CI: 4.29-6.11) to 3.78 (95% CI: 2.74-4.81) days. The incubation period increased with age (P< 0.001). A hierarchical prevention and control strategy against COVID-19 was implemented in Guangzhou, with Rt decreasing from 6.83 (95% credible interval [CrI]: 3.98-10.44) for the 7-day time window ending on 27 May 2021 to below 1 for the time window ending on 8 June and thereafter. Individuals with partial or full vaccination schedules with BBIBP-CorV or CoronaVac accounted for 15.3% of the COVID-19 cases. Clinical symptoms were milder in partially or fully vaccinated cases than in unvaccinated cases (odds ratio [OR] = 0.26 [95% CI: 0.07-0.94]). Conclusions/Significance The hierarchical prevention and control strategy against COVID-19 in Guangzhou was timely and effective. Authorised inactivated vaccines are likely to contribute to reducing the probability of developing severe disease. Our findings have important implications for the containment of COVID-19. Author summary On 11 May 2021, the WHO reclassified the B.1.617.2 variant as a "variant of concern" (VOC) from being a "variant of interest", considering its global public health significance. On 21 May 2021, the first local case infected with the Delta variant (i.e. lineage B.1.617.2) in Guangzhou, China, was reported. In response to the resurgence of COVID-19, the local government implemented a series of containment measures. This provides a valuable opportunity to understand the characteristics of the Delta variant and to evaluate the performance of inactivated COVID-19 vaccines (BBIBP-CorV and CoronaVac) and other interventions. We estimated that the median incubation period was 6.02 days and the means of serial intervals decreased from 5.19 to 3.78 days. The incubation period increased with age. The vaccination coverage in the COVID-19 cases was 15.3%. Clinical symptoms were milder in cases with partial or full vaccination than in those who were unvaccinated (odds ratio [OR] = 0.26). We found that the effective reproductive number decreased from 6.83 for the 7-day time window ending on 27 May 2021 to below 1 for the time window ending on 8 June and thereafter. Our findings have important implications for the containment of COVID-19.

Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021

Outbreak of SARS-CoV-2 Omicron Infection in a Centralized Quarantine Location in Hangzhou, China

An Outbreak of the SARS-CoV-2 Omicron Variant BA.1 — Zhuhai City, Guangdong Province, China, January 13, 2022

Transmission Patterns of Co-Circulation of Omicron Sub-Lineages in Hong Kong SAR, China, a City with Rigorous Social Distancing Measures, in 2022

Airborne Transmission of SARS-CoV-2 Delta Variant within Tightly Monitored Isolation Facility, New Zealand (Aotearoa)

Comparing the incubation period, serial interval, and infectiousness profile between SARS‐CoV‐2 Omicron and Delta variants

Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January–March 2022

Characterization of mild or asymptomatic patient admitted with Omicron variant of COVID-19 infection in Tibetan mobile cabin hospital China, August—October 2022

Household Transmission of SARS-CoV-2, Zhuhai, China, 2020

Omicron COVID-19 Variant Outcomes and Vaccination in Non-Severe and Non-Critical Patients at Admission

Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak

SARS-CoV-2 Infection Risk Imposed by Fully-vaccinated Air Travelers Attending an Island-confined Quarantine System Enabling Tourism During the Pandemic: A Retrospective Cohort Study

Nosocomial Outbreak by Delta Variant From a Fully Vaccinated Patient

High-rise buildings: A risk factor in the COVID-19 Omicron epidemic period

Importation and Transmission of SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern in Korea, November 2021

Household transmission of SARS-CoV-2 during the Omicron wave in Shanghai, China：a case-ascertained study

Transmission and Containment of the SARS-CoV-2 Delta Variant of Concern in Guangzhou, China: A Population-Based Study

Explosive household spread of the SARS-CoV-2 Omicron variant in China in late 2022

Household Transmission of SARS-CoV-2 During the Omicron Wave in Shanghai, China:a Case-Ascertained Study

Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building

Household transmission of SARS-CoV-2 during the Omicron wave in Shanghai, China: A case-ascertained study